Antibacterial Drug Discovery: Doing It Right

Tool Dissemination Doing It Right

B iomedical computing at academic research centers has been compared to a cottage industry. Lots of individuals work away on their focused research projects, generating useful algorithms. But quite often, the knowledge gained is lost when researchers move on to new projects. Yes, they might post their code on Web sites. But is it useful to anyone else without support and documentation? And how ...

What is the most important approach in current drug discovery: doing the right things or doing things right?

Doing the right things or doing things right: what is the most important focus for current drug discovery to secure delivery of new drugs of sustainable value to patients, healthcare professionals and healthcare providers? Some of the challenges faced today in drug discovery are addressed here: the relationship between R&D speed, cost and quality; how selection of performance metrics can affect...

Perioperative cardiac risk reduction: doing it right.

Attributing Creative Agency: Are we doing it right?

When contemplating the creativity of computational systems, a host of factors have been taken into consideration, many of which people have attempted to measure or otherwise operationalise: novelty, value, P-creativity versus H-creativity, exploration versus transformation, the subjective evaluation and contextualisation of the artefact, and so on. Whilst of equal importance, the systematic and...

Pre-Transfusion Serological Testing: Are we Doing it Right?

Pre-transfusion testing is performed to ensure the normal survival of transfused red blood cell products i.e. to prevent hemolytic transfusion reaction via immune-mediated mechanism [1]. The serological part of pre-transfusion testing includes; ABO group and Rh (D) type, antibody screening and crossmatching [2]. Antibody screening is included to detect unexpected antibody and was first introduc...